ORIGINAL RESEARCH article

Front. Surg., 17 May 2024

Sec. Genitourinary Surgery and Interventions

Volume 11 - 2024 | https://doi.org/10.3389/fsurg.2024.1336391

Bibliometric analysis of most cited Peyronie's disease and its management publications

  • MF

    Mehmet Fatih Şahin † *

  • ÇD

    Çağrı Doğan

  • MA

    Murat Akgül

  • CM

    Cenk Murat Yazıcı

  • SŞ

    Serkan Şeramet

  • HS

    Hulusi Sıtkı Dayısoylu

  • Department of Urology, Tekirdag Namık Kemal University Medical School, Tekirdağ, Türkiye

Abstract

Introduction:

Peyronie's disease (PD) is a common urologic illness, motivating numerous scientific investigations and publications. Scientific publications have more authors each year. A bibliometric review of the PD literature might help urologists and sexual medicine professionals comprehend publication tendencies in this subject. The current study was aimed at presenting a bibliometric analysis of PD, which is one of the important and trending subjects of andrology.

Methods:

On January 5, 2023, Web of Science scanned documents with the terms Peyronie's disease” “Peyronie's disease treatment”, “Peyronie's disease management”, “Peyronie's disease surgery” and “Peyronie's disease injection” from 1975 through 2023. Titles, years, authors, citations, citation indices, journal names, authors' countries of origin, article categories, and funding sources were recorded.

Results:

“Clinical Efficacy, Safety and Tolerability of Collagenase Clostridium Histolyticum for the Treatment of Peyronie Disease in 2 Large Double-Blind, Randomized, Placebo Controlled Phase 3 Studies” has the most citations and citation index. Most of the T100 articles were published in 2020, primarily in the Journal of Urology. These articles mainly focused on treatment, especially surgeries. All of these articles were in English, and the vast majority of them were by authors from the US who were most frequently collaborated with by other authors.

Conclusion:

This research analyzed the top 100 PD studies. This research focused on pathophysiology, innovative surgical procedures, and new approaches of PD. It also recommended bigger databases and more financing for research.

Introduction

Peyronie's disease (PD) is an acquired condition of the tunica albuginea with painful erections, curvature, and sexual dysfunction (1). It has a prevalence rate of 0.5%–20.3%, which may differ among different populations (2). PD is believed to occur due to microtrauma of the erect penis involving a wound and a scar (3). In diagnosis, although new methods are being developed to reveal possible causes such as calcified plaques, the number of studies on this subject is still limited (4). Oral pharmacotherapy is no longer recommended for treatment. Interferon alpha 2b and collagenase clostridium histolyticum (CCH) are the preferred injection therapies for patients who do not want surgery or who prefer minimal invasive interventions. Surgical procedures such as tunical lengthening, incision or excision with grafting, and tunical shortening are also possible. The disease itself causes pronounced physical and psychological distress for patients.

Bibliometric analysis is the study of data produced about a particular topic over a specific amount of time. This type of analysis enables a more comprehensive evaluation of the current literature and improved tracking of relevant material. The bibliometric technique facilitates the identification of the most significant authors, articles, publications, nations, and organizations in a specific field of research as well as the simultaneous analysis of several papers. In their future research, authors can save time by using bibliometric analysis, as it can be employed to summarize the most pertinent literature. Additionally, bibliometric analysis can highlight current patterns of treatment and give academics fresh insights. Authors who want to contribute to the literature by examining previous studies and their details can produce more distinguished and quality works with bibliometric analyses (5). Citations are helpful for gauging the quality of studies, interpreting scientific knowledge, and discovering new and evolving subjects that can constitute the focus of future research. They also provide useful quantitative data (6). Citation analysis is a recognized technique for evaluating the significance of a research paper, researcher, journal, nation, or year (7).

Great contributions are being made to the literature with the increasing number of urology studies, especially in the field of andrology. Although classical bibliometric analyses on andrological subjects such as erectile dysfunction and PD exist, there has been not much analysis on PD, despite it being a frequently occurring condition. Accordingly, the aim of the present study was to perform a bibliometric analysis of the top 100 (T100) most cited articles on PD that were published between 1975 and 2023 in order to identify significant advancements and trends in the field and to contribute to the methodologies and hypotheses included in subsequent research.

Materials and method

On January 5th, 2023, we searched Web of Science (Clarivate Analytics, Philadelphia, USA) papers published between 1975 and 2023 using the keywords “Peyronie's disease” “Peyronie's disease treatment”, “Peyronie's disease management”, “Peyronie's disease surgery” and “Peyronie's disease injection”. As a limitation, the study eliminated other databases like Google Scholar and Scopus, which would have had an impact on the quantity of papers returned, and we only used the Web of Science database. We have listed the resulting publications from the highest to the lowest according to the number of citations, with the most cited article residing at the top of the results list. Since the data for this study came from published literature, no ethical committee approval was necessary. The T100 articles were found among the search results for PD based on the quantity of citations. Two separate researchers (MFŞ and ÇD) independently analyzed the papers' abstracts and/or contents on any areas of disagreement to reach a consensus. Starting with the study that had the most citations, we examined each study individually. Those unrelated to PD were disregarded. We eliminated 23 records out of 123 articles as they were not relevant to the topic, making the 100th most cited article the 123rd on the list. For bibliometric analysis, the title of the article, the corresponding author, the source title, the publication year, the total number of citations, the number of articles, and the Adjusted Citation Index (ACI) were noted. In order to determine the ACI, which represents the yearly average number of citations, the number of citations was divided by the number of years since the article's publication. With the help of VOSviewer, co-authorship and co-citation analysis for the authors, co-authorship analysis for the authors according to country, and co-occurrence analysis for the authors according to keywords were analyzed. Finally, with the help of the Altmetric Bookmarklet, all of the Altmetric scores (AmS) of the publications were noted. The statistical analysis of the variables was performed by SPSS version 26.0 (IBM Corp., USA). The continuous variables of the study were summarized as medians and interquartile ranges (IQR), and the categorical variables were summarized as frequencies and percentages.

Results

The total number of publications after the search was 3,149, all of which were published between 1975 and 2023. The most cited T100 publications are listed in Table 1. The top 100 median ± IQR citation count was 98.50 ± 52 (range: 68–287) and the median ± IQR of the ACI was 5.05 ± 3.37 (range: 2.24–26.09). The oldest publication year was 1985 and the newest was 2016. The total number of authors ranged between 1 and 43 with a median ± IQR of 4 ± 3. The median AmS was found to be 2.0 ± 4.0 (range: 0–88). After the Spearman correlation, we found that there exists a positive but relatively weak correlation between the AmS and the number of citations (Spearman's rho = 0.334, %95 CI: 0.15–0.5, p < 0.001, n = 100).

Table 1

#PNCASTPYTCNoAACIAmS
1Clinical Efficacy, Safety and Tolerability of Collagenase Clostridium Histolyticum for the Treatment of Peyronie Disease in 2 Large Double-Blind, Randomized, Placebo Controlled Phase 3 StudiesGelbard, MartinJournal of Urology2013287926.0929
2Summary of the recommendations on sexual dysfunctions in menLue, Tom FJournal of Sexual Medicine20042762013.83
3The prevalence of Peyronie's disease: results of a large surveySchwarzer, UBJU International2001267611.6188
4Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screeningMulhall, JPJournal of Urology2004265813.253
5Proposal: Trauma as the cause of the Peyronie's lesionDevine, CJJournal of Urology199726249.73
6The Management of Peyronie's Disease: Evidence-based 2010 GuidelinesRalph, DavidJournal of Sexual Medicine2010257718.365
7An analysis of the natural history of Peyronie's diseaseMulhall, JPJournal of Urology2006251313.948
8Peyronie's Disease: AUA GuidelineNehra, AjayJournal of Urology20152331525.8918
9Summary of the Recommendations on Sexual Dysfunctions in MenMontorsi, FrancescoJournal of Sexual Medicine201022443164
10Peyronie's disease is associated with an increase in transforming growth factor-beta protein expressionElSakka, AIJournal of Urology1997189570
11EAU Guidelines on Penile CurvatureHatzimouratidis, KonstantinosEuropean Urology2012174814.53
12The Incidence of Peyronie's Disease in Rochester, Minnesota, 1950 Through 1984Lindsay, MbJournal Of Urology199117465.273
13The chronology of depression and distress in men with Peyronie's diseaseNelson, Christian J.Journal of Sexual Medicine2008170610.6311
14A retrospective review of 307 men with Peyronie's diseaseKadioglu, AJournal of Urology200216467.450
15Collagenase Versus Placebo in The Treatment of Peyronie's Disease—A Double-Blind-StudyGelbard, MKJournal of Urology199315344.946
16A surgical algorithm for the treatment of Peyronie's diseaseLevine, LAJournal of Urology199714825.480
17A New Treatment for Peyronie's-Disease—Modeling the Penis Over an Inflatable Penile ProsthesisWilson, SKJournal of Urology199414724.93
18The anatomy of the tunica albuginea in the normal penis and Peyronie's diseaseBrock, G;Journal of Urology199714555.373
19Use of intralesional verapamil to dissolve Peyronie's disease plaque: A long-term single-blind studyRehman, JUrology199814135.426
20A Population-Based Study of Peyronie's Disease: Prevalence and Treatment Patterns in the United StatesDiBenedetti, Dana BrittAdvances In Urology2011140510.770
21Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2b for minimally invasive treatment for Peyronie's diseaseHellstrom, Wayne J. G.Journal of Urology2006140137.781
22New Surgical-Treatment for Peyronie DiseaseEssed, EUrology198514023.590
23Impact of Peyronie's disease on sexual and psychosocial functioning: Qualitative findings in patients and controlsRosen, RaymondJournal of Sexual Medicine200813978.695
24Penile trauma: An etiologic factor in Peyronie's disease and erectile dysfunctionJarow, JPJournal of Urology199713625.043
25Risk factors for emotional and relationship problems in Peyronie's diseaseSmith, James F.Journal of Sexual Medicine200813458.387
26Intralesional Verapamil Injection for The Treatment of Peyronie's-DiseaseLevine, LAJournal of Urology199413334.430
27An animal model of Peyronie's-like condition associated with an increase of transforming growth factor beta mRNA and protein expressionElSakka, AIJournal of Urology199712964.786
28Fibrin deposition in Peyronie's disease plaqueSomers, KDJournal of Urology199712924.783
29Venous patch graft for Peyronie's disease. Part I: TechniqueLue, TFJournal of Urology199812824.921
30Evidence-Based Management Guidelines on Peyronie's DiseaseChung, EricJournal of Sexual Medicine20161221015.256
31Peyronie's disease: A reviewGholami, SSJournal of Urology200312255.810
32Experience with intraplaque injection of verapamil for Peyronie's diseaseLevine, LAJournal of Urology200212135.53
33Peyronie's disease: Etiology, medical, and surgical therapyHellstrom, WJGJournal Of Andrology200012125.040
34The Nesbit Operation for Peyronie's-Disease—16-Year ExperienceRalph, DJJournal of Urology199512134.170
35Bother and Distress Associated with Peyronie's Disease: Validation of the Peyronie's Disease QuestionnaireHellstrom, Wayne J. G.Journal of Urology2013120610.911
36Venous patch graft for Peyronie's disease. Part II: Outcome analysisEl-Sakka, AIJournal of Urology199812034.620
37Mechanisms of disease: new insights into the cellular and molecular pathology of Peyronie's diseaseGonzalez-Cadavid, NFNature Clinical Practice Urology200511325.951
38Ultrastructural-Changes in Impotent Penile Tissue—A Comparison Of 65 PatientsMersdorf, AJournal of Urology199111373.423
39Tamoxifen versus placebo in the treatment of Peyronie's diseaseTeloken, CJournal of Urology199911264.483
40Mechanisms of Penile FibrosisGonzalez-CadavidJournal of Sexual Medicine200911027.337
41Intratunical Injection of Human Adipose Tissue-derived Stem Cells Prevents Fibrosis and Is Associated with Improved Erectile Function in a Rat Model of Peyronie's DiseaseCastiglione, FabioEuropean Urology201310999.911
42Potassium paraaminobenzoate (POTABTM)) in the treatment of Peyronie's disease: A prospective, placebo-controlled, randomized studyWeidner, WEuropean Urology200510735.633
43Epidemiology of Peyronie's diseaseSommer, FInternational Journal of Impotence Research200210774.860
44Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contractureQian, AUrology200410545.250
45Evidence based assessment of long-term results of plaque incision and vein grafting for Peyronie's diseaseMontorsi, FJournal of Urology2000102104.250
46A First Prospective, Randomized, Double-Blind, Placebo-Controlled Clinical Trial Evaluating Extracorporeal Shock Wave Therapy for the Treatment of Peyronie's DiseasePalmieri, AlessandroEuropean Urology200910186.732
47The Treatment of Peyronie's Disease with TamoxifenRalph, DJBritish Journal of Urology199210143.166
48Effect of nitric oxide on the differentiation of fibroblasts into myofibroblasts in the Peyronie's fibrotic plaque and in its rat modelVernet, DNitric Oxide-Biology and Chemistry200210074.559
49Phase 2b Study of the Clinical Efficacy and Safety of Collagenase Clostridium Histolyticum in Patients with Peyronie DiseaseGelbard, MartinJournal of Urology20129968.251
50Peyronie's disease: Prevalence and association with cigarette smoking—A multicenter population-based study in men aged 50–69 yearsLa Pera, GEuropean Urology200199114.30
51Psychological Impact of Peyronie's Disease: A ReviewNelson, Christian J.Journal of Sexual Medicine20139828.914
52Penile traction therapy for treatment of Peyronie's disease: A single-center pilot studyLevine, Laurence A.Journal of Sexual Medicine20089535.944
53Long-term follow-up of treatment for Peyronie's disease: Modeling the penis over an inflatable penile prosthesisWilson, SKJournal of Urology20019534.130
54Sexual dysfunction in Peyronie's disease: An analysis of 222 patients without previous local plaque therapyWeidner, WJournal of Urology19979543.520
55Effects of long-term vardenafil treatment on the development of fibrotic plaques in a rat model of Peyronie's diseaseFerrini, MGBJU International20069455.229
56Regulation Of the Proliferation and Biosynthetic Activities of Cultured Human Peyronie's Disease Fibroblasts by Interferons-Alpha, Interferons-Beta and Interferons-GammaDuncan, MRScandinavian Journal of Urology and Nephrology19919132.766
57Combination of Penile Traction, Intralesional Verapamil, and Oral Therapies for Peyronie's DiseaseAbern, Michael R.Journal of Sexual Medicine20128937.426
58Five-Year Follow-Up of Peyronie's Graft Surgery: Outcomes and Patient SatisfactionChung, EricJournal of Sexual Medicine20118946.852
59Peyronie's diseasePryor, JohnJournal of Sexual Medicine200489104.450
60A rat model of Peyronie's disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expressionBivalacqua, TJJournal of Urology20008983.713
61Inflatable Penile Prosthesis Placement in Men with Peyronie's Disease and Drug-resistant Erectile Dysfunction: A Single-Center StudyLevine, Laurence A.Journal of Sexual Medicine20108836.290
62Use of porcine small intestinal submucosal graft in the surgical management of Peyronie's diseaseKnoll, LDUrology20018813.833
63Is Colchicine Effective in Peyronie's-Disease -A Pilot-StudyAkkus, EUrology19948862.930
64Peyronie's Disease Following Radical Prostatectomy: Incidence and PredictorsTal, RaananJournal of Sexual Medicine20108766.210
65The use of intralesional clostridial collagenase injection therapy for Peyronie's disease: A prospective, single-center, non-placebo-controlled studyJordan, Gerald H.Journal of Sexual Medicine20088715.446
66A surgical algorithm for men with combined Peyronie's disease and erectile dysfunction: Functional and satisfaction outcomesMulhall, JJournal of Sexual Medicine20058734.580
67Use of Penile Extender Device in the Treatment of Penile Curvature as a Result of Peyronie's Disease. Results of a Phase II Prospective StudyGontero, PaoloJournal of Sexual Medicine20098675.735
68Surgical correction of Peyronie's disease via Tunica Albuginea plication or partial plaque excision with pericardial graft: Long-term follow upTaylor, Frederick L.Journal of Sexual Medicine20088625.380
69Peyronie's disease (CME)Bella, Anthony J.Journal of Sexual Medicine20078645.060
70Risk factors for Peyronie's disease: a case-control studyBjekic, MDBJU International20068644.780
71Structural alterations in the tunica albuginea of the penis: Impact of Peyronie's disease, ageing and impotenceAkkus, EBritish Journal of Urology19978573.150
72Peyronie's disease cell culture models: phenotypic, genotypic and functional analysesMulhall, JPInternational Journal of Impotence Research20028443.820
73Acetyl-L-carnitine vs. tamoxifen in the oral therapy of Peyronie's disease: a preliminary reportBiagiotti, GBJU International20018423.653
74Standard Operating Procedures for Peyronie's DiseaseLevine, Laurence A.Journal of Sexual Medicine20138327.554
75Fibrin as an inducer of fibrosis in the tunica albuginea of the rat: a new animal model of Peyronie's diseaseDavila, HHBJU International20038343.953
76Effect of intralesional verapamil for treatment of Peyronie's disease: a randomized single-blind, placebo-controlled studyShirazi, M.International Urology and Nephrology20098255.470
77Graft materials in Peyronie's disease surgery: A comprehensive reviewKadioglu, AtesJournal of Sexual Medicine20078264.820
78Surgical treatment of Peyronie's disease: A critical analysisKadioglu, AtesEuropean Urology20068264.563
79Penile Vascular Evaluation of Men with Peyronie's DiseaseLopez, JAJournal of Urology19938222.650
80Peyronie's diseaseTaylor, Frederick L.Urologic Clinics of North America20077924.650
81Clinical Safety and Effectiveness of Collagenase Clostridium Histolyticum Injection in Patients with Peyronie's Disease: A Phase 3 Open-Label StudyLevine, Laurence A.Journal of Sexual Medicine20157898.671
82Comparison of vitamin E and propionyl-L-carnitine, separately or in combination, in patients with early chronic Peyronie's disease: A double-blind, Placebo Controlled, Randomized studySafarinejad, Mohammad RezaJournal of Urology20077734.530
83Therapeutic effects of colchicine in the management of Peyronie's disease: a randomized double-blind, placebo-controlled studySafarinejad, MRInternatıonal Journal of Impotence Research20047713.850
84Histological and ultrastructural alterations in an animal model of Peyronie's diseaseEl-Sakka, AIBritish Journal of Urology19987762.966
85Treatment of Peyronie's disease with intralesional verapamil injectionLevine, LAJournal of Urology19977612.810
86Results of surgical treatment for abnormal penile curvature: Peyronie's disease and congenital deviation by modified Nesbit plication (tunical shaving and plication)Rehman, JJournal of Urology19977542.780
87Patient-Partner Satisfaction with Semirigid Penile Prostheses for Peyronie's-Disease—A 5-Year Follow-Up-StudyMontorsi, FJournal of Urology19937542.420
88A New, Innovative, Lengthening Surgical Procedure for Peyronie's Disease by Penile Prosthesis Implantation with Double Dorsal-Ventral Patch Graft: The Sliding TechniqueRolle, LuigiJournal of Sexual Medicine20127486.175
89The prevalence of Peyronie's disease in diabetic patients with erectile dysfunctionArafa, MInternational Journal of Impotence Research20077454.350
90The results of plaque incision and venous grafting (Lue procedure) to correct the penile deformity of Peyronie's diseaseKalsi, JBJU International20057443.890
91Clinical presentations of Peyronie's diseasePryor, JPInternational Journal of Impotence Research20027423.360
92Application of pericardial graft in the surgical management of Peyronie's diseaseHellstrom, WJGJournal of Urology20007423.080
93Venogenic Impotence Following Dermal Graft Repair for Peyronie's DiseaseDalkin, BLJournal of Urology19917422.240
94Surgery for Peyronie's diseaseLevine, Laurence AAsian Journal of Andrology20137326.640
95Verapamil versus saline in electromotive drug administration for Peyronie's disease: A double-blind, placebo-controlled trialGreenfield, Jason MJournal of Urology20077334.293
96A critical analysis of nonsurgical treatment of Peyronie's diseaseHauck, Ekkehard W.European Urology200672446
97A case-control study on risk factors for Peyronie's diseaseCarrieri, MPJournal Of Clinical Epidemiology19987252.773
98Simultaneous Penile Lengthening and Penile Prosthesis Implantation in Patients with Peyronie's Disease, Refractory Erectile Dysfunction, and Severe Penile ShorteningSansalone, SalvatoreJournal of Sexual Medicine20127185.925
99Expanding the paradigm for plaque development in Peyronie's diseaseMulhall, JPInternational Journal of Impotence Research20036913.290
100Restoration of Penile Function and Patient Satisfaction with Intralesional Collagenase Clostridium Histolyticum Injection for Peyronie's DiseaseZiegelmann, Matthew J.Journal of Urology20166868.52

The top 100 cited articles about peyronie's disease (PD).

PN, Publication Name; CA, Corresponding Author; ST, source title; PY, publication year; TC, total citations; NoA, number of authors; ACI, Adjusted Citation Index; AmS: Altmetric score.

The highest number of papers were published in 2020, according to an analysis of the articles' date of publication, and the maximum number of citations were also found in 2020. (Figure 1). When the journals with the highest portion of the T100 articles were examined, the Journal of Urology was found to have the most publications, followed by the Journal of Sexual Medicine (Figure 2).

Figure 1

Figure 2

One-half of the T100 journals focused on the treatment of PD, while 28% focused on general topics such as epidemiology, prevalence, and recommendations, and 22% examined pathophysiology. Concerning treatment, 34% of the T100 articles examined surgery, 26% concentrated on intralesional injections, and 14% focused on oral treatments (Figure 3). The studies included in the T100 were mainly concerned with recommendations, prevalence, relationship with trauma, intracavernous injections, and etiology.

Figure 3

Analysis of the authors of the T100 articles showed that the author with the highest total number of citations was Lue TF, MD, with a total of 1,357 citations and 11 articles, while the author with the highest number of articles was Levine Laurence A, MD, with 9 articles. Co-authorship and co-citation analysis for the authors is presented in Figure 4 (minimum number of articles: 2 and above) and Figure 5 (minimum number of citations: 10 and above).

Figure 4

Figure 5

As expected, all of the articles were published in English. The distributions of articles according to country was as follows: 64% US, 11% Italy, and 25% others (Germany, England, Turkey, etc.) (Figure 6).

Figure 6

The analysis of keywords showed that the top 10 keywords were as follows: Peyronie's disease, penis, penile induration, erectile dysfunction, fibrosis, penile prosthesis, impotence, collagen, tunica albuginea, and risk factors (Figure 7).

Figure 7

Discussion

Bibliometric analysis is useful for several reasons. For example, it can identify and highlight the contributions of colleagues and forebearers, acknowledge significant urological advancements, and provide a helpful historical context for current trends in the field. The urological literature can be examined using citation analysis, which also reveals quantitative data about authors, subjects, countries, and journals that are useful for finding classic works and high-impact publications (6).

Altmetric analysis is a method that tracks the influence of a publication in the online area, rather than within academic circles. It enables us to quantify the extent to which a scientific study is referenced across different online platforms, including social media, blogs, news outlets, and podcasts. Additionally, it measures the number of online views and downloads. Most of the publications about PD' AmS are found to be very low. But in our study, like Kolahi et al., we found a positive but weak correlation between the number of citations and AmS (7). However, it is important to acknowledge that altmetrics is a relatively recent notion within the academic community. Furthermore, the growing awareness and use of social media among researchers in the future may potentially amplify this association. This shows that this issue is a phenomenon that has gained a place in the academic world rather than being a popular problem among people.

Many factors influence the number of citations an article receives. Articles typically receive the most citations 3–10 years after their publication (8). Older articles are more likely to be cited (9), but when detailed analyses were performed in the current study, it was seen that most articles and citations both occurred in 2020. As such, this year can be considered to be a milestone in PD research, generating a better understanding of the disease, including its etiology, anatomy, predisposing factors, histological structure, and surgical and non-surgical techniques. None of the most cited articles were published in the last five years. More than one-half of the publications in the T100 were published in the Journal of Urology and Journal of Sexual Medicine, both of which have a high impact factor and h-index. This could be a sign that scientists want to publish their works in prestigious publications related to PD. These two journals have a considerably great impact on studies that examine PD and can be regarded as references for articles listed in the T100. Most of the studies were conducted by individual scientists, and a few studies in the T100 were found by a study group using a multicenter database. Contrary to collaborative disciplines such as urooncology or urogynecology, multicenter studies on andrology and PD are needed rather than single-center studies.

We also found that one-half of the papers on PD concerned treatment, while older publications mostly focused on pathophysiology. Newer studies focused on new surgical methods and approaches. Among these studies, surgeries were the most common subject, followed by intralesional injections. The publication with the highest number of citations was also included in this section. Intralesional CCH has been used in the treatment of PD since 1985, with the author who published the first article being the same author of the most cited article (10). In a randomized controlled trial, Gelbard et al. stated that intralesional CCH provided a significant improvement in plaque size and penile deformity compared to a placebo (11). This article also occupied the 15th place in the T100 list. Intralesional verapamil (12) and interferon alpha-2b (13) are the other treatment modalities seen in the T100 list with the most citations. Although the most cited publication was on intralesional injections, the most cited articles on treatment options concentrated on surgical methods. The Nesbit technique is the oldest surgical method used in the treatment of PD (14). However, in the publications on the T100 list, articles about graft materials stood out as a new trend. When examined in a more limited group, we can see that the first 10 articles were generally related to etiology and pathophysiology. For this, it was observed that there are very few surgeries and interventional procedures, and only one publication was found to be about injections. Since most of these subjects have been examined in relation to PD, multicenter randomized prospective studies about surgery are needed.

The US had the highest number of articles in the T100. This is not surprising since the studies with the greatest funding are from the US (15). According to a review of co-authorship analysis for authors according to country using VOSviewer, the US had the highest link strength. Christiansen et al. found that only 15.1% of articles written about PD had a funding source in 2020. Other articles appeared to be self-funded (15). This may suggest that it is easier to perform research in high-income countries, such as the US and some European countries, compared to other, developing countries. A newly published article about Peyronie's disease and bibliometric analysis has been published, but it has not been focused on funding issues, which we think are very important for scientific developments (16). A total of three studies from our country, Turkey, are included in this list, and although surgery is frequently performed in Turkey, they are in the category of current literature analysis or review articles due to lower income and difficulties in drug supply. We believe that further studies will be interrupted and new developments will be stymied due to a lack of funding on such a developmental subject in andrology. In our study, 19% of the T100 studies had a funding source that slightly increased in two years. This finding leads us to the conclusion that good material resources facilitate the development of science, and that this increase in funding provides hope for the future of research on PD. By doing more research on the pathological sequence of cellular and molecular processes and deepening our comprehension of the pathophysiology of PD via animal models, the achievement of new and efficient medical treatments and management modalities will become a feasible goal.

This study had some limitations. First, the study eliminated other databases like Google Scholar and Scopus, which would have had an impact on the quantity of papers returned, and we only used the Web of Science database. Second, self-citations and interactions between citations were not examined. Third, we only investigated the top 100 articles with the most citations, so it is possible that we missed some more significant articles with fewer citations.

Conclusion

Our study was the first to analyze the top 100 most cited studies about Peyronie's disease (PD). In the T100 list, the Journal of Urology and the Journal of Sexual Medicine were the leading journals. The vast majority of the articles were focused on treatments of the disease, with surgery being the predominant topic. The US was the leading country with the most publications. Future research is anticipated to benefit from and be guided by the insights produced in this study. Novel therapies like stem cells, new greft materials with new plication techniques, and new medical treatment modalities are interesting hot research topics. Lastly, there is a need for further studies that include larger databases and receive greater funding.

Statements

Author’s note

In this article, MFŞ and ÇD get part at substantial contributions to conception and design, MA and SŞ at drafting and revising the article critically for important intellectual content and CMY and HSD get part at final approval of the version to be published.

Data availability statement

The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.

Ethics statement

Ethical approval was not required for this study, as this is a retrospective study performing secondary analysis, and involved no direct procedures on living beings or human data. The previous original studies involving human participants would have been reviewed and approved by their relevant review boards.

Author contributions

MFŞ: Conceptualization, Methodology, Writing – original draft, Writing – review & editing. ÇD: Conceptualization, Methodology, Writing – original draft. MA: Writing – review & editing. CY: Writing – review & editing. SŞ: Writing – review & editing. HD: Writing – review & editing.

Funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

  • 1.

    KriegerJRRizkPJKohnTPPastuszakA. Shockwave therapy in the treatment of Peyronie's disease. Sex Med Rev. (2019) 7(3):499507. 10.1016/j.sxmr.2019.02.001

  • 2.

    NehraAAlterowitzRCulkinDJFaradayMMHakimLSHeidelbaughJJet alPeyronie’s disease: AUA guideline. J Urol. (2015) 194(3):74553. 10.1016/j.juro.2015.05.098

  • 3.

    OstrowskiKAGannonJRWalshTJ. A review of the epidemiology and treatment of Peyronie’s disease. Res Rep Urol. (2016) 8:6170. 10.2147/RRU.S65620

  • 4.

    TramaFIllianoEIaconoFRuffoAdi LauroGAvetaAet alUse of penile shear wave elastosonography for the diagnosis of Peyronie’s disease: a prospective case–control study. Basic Clin Androl. (2022) 32(1):18. 10.1186/s12610-022-00164-w

  • 5.

    TemelMHErdemİHKulABağcıerF. Bibliometric analysis of the top 100 most-cited articles on the treatment of osteoporosis. Arch Osteoporos. (2022) 17(1):112. 10.1007/s11657-022-01141-6

  • 6.

    SuzanVBektan KanatBYavuzerHDoventasA. Themes and trends for osteoporosis: the bibliometric and altmetric approach. Arch Osteoporos. (2021) 16(1):122. 10.1007/s11657-021-00983-w

  • 7.

    KolahiJKhazaeiSIranmaneshPKimJBangHKhademiA. Meta-analysis of correlations between altmetric attention score and citations in health sciences. BioMed Res Int. (2021) 2021:111. 10.1155/2021/6680764

  • 8.

    ShahidIMotianiVSiddiqiTJUsmanMSKumarJHussainAet alCharacteristics of highly cited articles in heart failure: a bibliometric analysis. Future Cardiol. (2020) 16:18997. 10.2217/fca-2019-0016

  • 9.

    HeldMCasteleinSBruinsM-FLaubscherMDunnRKeelMet alMost influential literature in spinal tuberculosis: a global disease without global evidence. Glob Spine J. (2018) 8:8494. 10.1177/2192568217707182

  • 10.

    GelbardMKLindnerAKaufmanJJ. The use of collagenase in the treatment of Peyronie’s disease. J Urol. (1985) 134(2):2803. 10.1016/s0022-5347(17)47123-0

  • 11.

    GelbardMKJamesKRiachPDoreyF. Collagenase versus placebo in the treatment of Peyronie’s disease: a double-blind study. J Urol. (1993) 149(1):568. 10.1016/s0022-5347(17)35998-0

  • 12.

    LevineLAMerrickPFLeeRC. Intralesional verapamil injection for the treatment of Peyronie’s disease. J Urol. (1994) 151(6):15224. 10.1016/s0022-5347(17)35291-6

  • 13.

    HellstromWJKendirciMMaternRCockerhamYMyersLSikkaSCet alSingle-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon α-2b for minimally invasive treatment for Peyronie’s disease. J Urol. (2006) 176(1):3948. 10.1016/S0022-5347(06)00517-9

  • 14.

    NesbitRM. Congenital curvature of the phallus: report of three cases with description of corrective operation. J Urol. (1965) 93(2):2302. 10.1016/S0022-5347(17)63751-0

  • 15.

    ChristiansenASmelserWBroghammerJDeibertCM. Funding Peyronie’s disease: funding sources for primary research literature. Int J Impot Res. (2021) 33(1):825. 10.1038/s41443-020-0244-6

  • 16.

    GaoDShenYTangBMaZChenDAYuXet alThe 100 most-cited publications on Peyronie’s disease: a bibliometric analysis and visualization study. Int J Impot Res. (2023) 36(2):1107. 10.1038/s41443-023-00703-7

Summary

Keywords

Peyronie’s disease, number of citations, bibliometric analysis, adjusted citation index, altmetric score

Citation

Şahin MF, Doğan Ç, Akgül M, Yazıcı CM, Şeramet S and Dayısoylu HS (2024) Bibliometric analysis of most cited Peyronie's disease and its management publications. Front. Surg. 11:1336391. doi: 10.3389/fsurg.2024.1336391

Received

10 November 2023

Accepted

06 May 2024

Published

17 May 2024

Volume

11 - 2024

Edited by

Jafar Kolahi, Independent Researcher, Isfahan, Iran

Reviewed by

Achille Aveta, University of Naples Federico II, Italy

Pedram Iranmanesh, Isfahan University of Medical Sciences, Iran

Updates

Copyright

*Correspondence: Mehmet Fatih Şahin

ORCID Mehmet Fatih Şahin orcid.org/0000-0002-0926-3005 Çağrı Doğan orcid.org/0000-0001-9681-2473 Murat Akgül orcid.org/0000-0001-6187-1940 Cenk Murat Yazıcı orcid.org/0000-0001-6140-5181

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics